Literature DB >> 11779124

Molecular regulation of muscle cachexia: it may be more than the proteasome.

Per-Olof Hasselgren1, Curtis Wray, Joshua Mammen.   

Abstract

Muscle cachexia induced by sepsis, severe injury, cancer, and a number of other catabolic conditions is mainly caused by increased protein degradation, in particular breakdown of myofibrillar proteins. Ubiquitin-proteasome-dependent proteolysis is the predominant mechanism of muscle protein loss in these conditions, but there is evidence that several other regulatory mechanisms may be important as well. Some of those mechanisms are reviewed in this article and they include pre-, para-, and postproteasomal mechanisms. Among preproteasomal mechanisms, mediators, receptor binding, signaling pathways, activation of transcription factors, and modification of proteins are important. Several paraproteasomal mechanisms may influence the trafficking of ubiquitinated proteins and their interaction with the proteasome, including the expression and activity of the COP9 signalosome, the carboxy terminus of heat shock protein 70-interacting protein (CHIP) and valosin-containing protein (VCP). Finally, because the proteasome does not degrade proteins completely into free amino acids but into peptides, postproteasomal degradation of peptides by the giant protease tripeptidyl peptidase II (TPP II) and various aminopeptidases is important in muscle catabolism. Thus, multiple mechanisms and regulatory steps may influence the breakdown of ubiquitinated muscle proteins by the 26S proteasome. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779124     DOI: 10.1006/bbrc.2001.5849

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Psychological stress and aging: role of glucocorticoids (GCs).

Authors:  K M Mehedi Hasan; Md Shaifur Rahman; K M T Arif; Mahbub E Sobhani
Journal:  Age (Dordr)       Date:  2011-10-05

2.  Properties of easily releasable myofilaments: are they the first step in myofibrillar protein turnover?

Authors:  Girija Neti; Stefanie M Novak; Valery F Thompson; Darrel E Goll
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-25       Impact factor: 4.249

Review 3.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 4.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

5.  Molecular architecture and assembly mechanism of Drosophila tripeptidyl peptidase II.

Authors:  Beate Rockel; Jürgen Peters; Shirley A Müller; Gönül Seyit; Philippe Ringler; Reiner Hegerl; Robert M Glaeser; Wolfgang Baumeister
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Hybrid molecular structure of the giant protease tripeptidyl peptidase II.

Authors:  Crystal K Chuang; Beate Rockel; Gönül Seyit; Peter J Walian; Anne-Marie Schönegge; Jürgen Peters; Petrus H Zwart; Wolfgang Baumeister; Bing K Jap
Journal:  Nat Struct Mol Biol       Date:  2010-08-01       Impact factor: 15.369

7.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 8.  Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.

Authors:  Yuji Miyamoto; Diana L Hanna; Wu Zhang; Hideo Baba; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

9.  Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle.

Authors:  Thomas C Vary; Robert A Frost; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-09       Impact factor: 3.619

Review 10.  Epigenetic drugs in the treatment of skeletal muscle atrophy.

Authors:  Valentina Guasconi; Pier Lorenzo Puri
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.